The Place of FDG PET/CT in Renal Cell Carcinoma: Value and Limitations
Unlike for most other malignancies, application of FDG PET/CT is limited for renal cell carcinoma (RCC), mainly due to physiological excretion of FDG from the kidneys, which decreases contrast between renal lesions and normal tissue, and may obscure or mask the lesions of the kidneys. Published clin...
| Hlavní autor: | |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Frontiers Media S.A.
2016-09-01
|
| Edice: | Frontiers in Oncology |
| Témata: | |
| On-line přístup: | http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00201/full |